Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial
Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification (INSIGHT)
Sponsor: Roswell Park Cancer Institute
This NA trial investigates Head and Neck Squamous Cell Carcinoma and is currently ongoing. Roswell Park Cancer Institute leads this study, which shows 11 recorded versions since 2022 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Nov 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Aug 2025 — Nov 2025 [monthly]
Active Not Recruiting NA
Status: Suspended → Active Not Recruiting
-
Mar 2025 — Aug 2025 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jan 2025 — Mar 2025 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2022 — Sep 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
-
May 2022 — Jul 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Roswell Park Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .